Ocular Therapeutix Inc. buy Royal Bank of Canada
Start price
18.03.25
/
50%
€6.81
Target price
18.03.26
€15.58
Performance (%)
-14.89%
Price
18:16
€5.79
Summary
This prediction is currently active. The price of Ocular Therapeutix Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.89%. This prediction currently runs until 18.03.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ocular Therapeutix Inc. | -22.325% | -22.325% |
| iShares Core DAX® | 0,19 % | -1,22 % |
| iShares Nasdaq 100 | -1,35 % | -5,31 % |
| iShares Nikkei 225® | -0,43 % | 7,32 % |
| iShares S&P 500 | -1,01 % | -3,40 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $17.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat